Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/20049927

Download in:

View as

General Info

PMID
20049927